Skip to Content
Merck
CN
  • A protocol for the generation of EPO - Producing neural crest cells from human induced pluripotent stem cells.

A protocol for the generation of EPO - Producing neural crest cells from human induced pluripotent stem cells.

MethodsX (2022-06-28)
Angelo Michele Lavecchia, Sara Buttò, Christodoulos Xinaris
ABSTRACT

Insufficient production of erythropoietin (EPO) leads to anaemia. Developing methods for the generation and transplantation of EPO-producing cells would allow scientists to design personalised therapeutic solutions. Here we present a simple and highly reproducible protocol for the generation of neural crest cells (NCCs) that can produce and secrete erythropoiesis-competent EPO in response to hypoxia.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
holo-Transferrin human, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
Insulin solution human, sterile-filtered, BioXtra, suitable for cell culture
Sigma-Aldrich
Y-27632 dihydrochloride, ≥98% (HPLC)